AnGes Takes DNA Vaccine Tack As It Enters Virus R&D Fray
Japan Venture Joins Others In Same Approach
Japanese bioventure goes down the DNA vaccine route, along with several others worldwide, pointing to potential development speed and safety advantages.
You may also be interested in...
Coronavirus Update: Sinovac Gets $15m Towards CoronaVac Phase II, Remdesivir Early Access In UK
Multiple vaccine and drug developers across the world report progress and partnerships amid volatility in their shares.
White House Hypes Chloroquine, A Drug Currently In Shortage, As Coronavirus Treatment Hope
Efficacy trials are under way and one supplier already has said it would restart production to meet the anticipated demand.
Coronavirus Hasn’t Sparked CURE ID Physician Social Network Interest
US FDA/NIH smartphone app is intended to allow clinicians and others to talk about potential treatments for infectious diseases, but so far COVID-19-related activity has been limited.